Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey


ÇELİK İ., BEŞTEPE DURSUN Z., TÜRE YÜCE Z., İnanıcı B.

Virology: Research and Reviews, cilt.1, sa.2, ss.1-3, 2017 (Hakemli Dergi)